Early Phase 1
N=20
Osteopathy in Chronic Obstructive Pulmonary Disease (COPD) Rehabilitation Trial
Chronic Obstructive Pulmonary Disease
Bottom Line
View on ClinicalTrials.gov: NCT00637299 ↗Enrolled (actual)
20
Serious AEs
—
Results posted
Apr 2009
Primary outcome: Primary: Walking Ability — 369.5; 304.7 meters — p=<0.01
Study Design & Population
- Study type
- Interventional
- Phase
- Early Phase 1
- Interventions
- Active osteopathic treatment (OMT+PR): Active Comparator (Other); sham osteopathic treatment (SOT+PR) (Other)
- Age
- Adult, Older Adult · 45+ yrs
- Sex
- All
- Sponsor
- Fondazione Salvatore Maugeri
- Primary completion
- Jul 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Walking Ability |
369.5; 304.7 | <0.01 sig |
| SECONDARY Lung Function Test |
3.09; 4.23 | <0.05 sig |
Summary
The purpose of this trial is to verify if an osteopathic treatment added to usual pulmonary rehabilitation trial is able to improve the walking ability of COPD patients and if there is any influence on lung functionality.
Eligibility Criteria
Inclusion Criteria
- patients affected by COPD
Exclusion Criteria
- other diseases other than COPD
Data sourced from ClinicalTrials.gov (NCT00637299). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.